ID

24891

Description

Study ID: 101468/166 Clinical Study ID: SKF-101468/166 Study Title: A Phase II, randomised, double-blind, active-controlled, dose-escalation study to determine the maximum well-tolerated starting dose of a new formulation of ropinirole in Parkinson's Disease patients not receiving other dopaminergic therapies Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Parkinson Disease

Keywords

Versions (3)
  1. 8/22/17 8/22/17 -
  2. 8/22/17 8/22/17 -
  3. 9/4/17 9/4/17 -
Uploaded on

August 22, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

randomization determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166

English

randomization determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166

1 forms  
Administrative Data
Description

Administrative Data

Alias
UMLS CUI-1
C1320722
Patient Initials
Description

patient's initials

Data type

text

Alias
UMLS CUI [1]
C2986440
Patient No.
Description

patient number

Data type

integer

Alias
UMLS CUI [1]
C1830427
Date of Visit
Description

date of visit

Data type

date

Alias
UMLS CUI [1]
C1320303
RANDOMIZATION AND COHORT ASSIGNMENT
Description

RANDOMIZATION AND COHORT ASSIGNMENT

Alias
UMLS CUI-1
C0034656
After review of all eligibility criteria is the patient eligible for the study?
Description

patient eligible for clinical trial

Data type

text

Alias
UMLS CUI [1]
C1302261
Randomization Number
Description

randomization numb

Data type

integer

Alias
UMLS CUI [1]
C2986235
Back to the top of the page

Similar models

randomization determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
patient's initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
patient number
Item
Patient No.
integer
C1830427 (UMLS CUI [1])
date of visit
Item
Date of Visit
date
C1320303 (UMLS CUI [1])
Item Group
RANDOMIZATION AND COHORT ASSIGNMENT
C0034656 (UMLS CUI-1)
Item
After review of all eligibility criteria is the patient eligible for the study?
text
C1302261 (UMLS CUI [1])
patient eligible for clinical trial
Code List
After review of all eligibility criteria is the patient eligible for the study?
CL Item
Yes - Please telephone the Central Randomization Center to enroll the patient. Record the assigned (1)
CL Item
Randomization Number and check the appropriate box to indicate the assigned Cohort in the (Randomization Number and check the appropriate box to indicate the assigned Cohort in the)
CL Item
section below. (section below.)
CL Item
No - Record the reason for Screen Failure on the "Patient Screening/Enrollment Log." (2)
randomization numb
Item
Randomization Number
integer
C2986235 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial